While these compounds showed dose-dependent stabilization of p53 and sensitivity in cells with wild-type p53, they failed to induce any p53-regulated tumor suppressive effects in cells harboring mutant or non-functional p53 46. This evidence concerns the gene TP53 and neoplasm.